Elucidating the precise pharmacological system of action (MOA) of Normally happening compounds might be hard. Despite the fact that Tarselli et al. (60) developed the very first de novo artificial pathway to conolidine and showcased that this Normally occurring compound efficiently suppresses responses to both equally chemically induced and inflamm